Skip to content
Taking Tamoxifin after breast cancer surgery
SaralynB posted:
I took Tamoxifin 10 mo. after my mastectomy, when my Gyn. doctor found uterine cancer. Neither my surgeon nor my oncologist warned me that 18% of women who take tamoxifin get uterine cancer! This is unacceptable. Patients should be warned!!
Was this Helpful?
9 of 15 found this helpful
rachael67 responded:
Yes, "full disclosure" should be a part of any info given to a patient so that they might better make a choice for themselves. However, to be fair to the docs, not all are aware of side-effects. etc. YES! They should be, but the reasons they aren't might not be simple. Sometimes the drug companies hide the info and/or the government. Sometimes there is just too much info for them to keep track of it? And, sadly, sometimes they assume they "know it all" and/or don't care enough to keep on top of it!

But, should patients be warned? YOU BET!

Hoping you are doing well now and in the future!

Just when the caterpillar thought her world was over, she became a butterfly! Don't give up five minutes before the miracle!!
jenna291 responded:
Wow, 18% is unacceptable. I took tamoxifen for1 1/2 years then was switched to arimidex, which I am currently taking, because I had gone thru medically induced menopause. I never heard that number, but did see on my prescription sheet that uterine cancer could be a side effect. I rolled the dice, but honestly you don't know what to do and take faith that your doctors are doing the best thing for you at the time.
God Bless You and you are in my thoughts and prayers for a healthy future!

Helpful Tips

How to more easily read discussions
Exchanges provide a more dynamic way to keep up with ongoing discussions. But If you're finding how discussions and responses are ... More
Was this Helpful?
28 of 47 found this helpful

Related Drug Reviews

  • Drug Name User Reviews

Report Problems With Your Medications to the FDA

FDAYou are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

For more information, visit the Duke Health Breast Cancer Center